Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

EASYMED ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   3.4% 4.4% 12.8% 6.8% 4.7% 9.1% 16.8% 16.5%   Credit score (0-100)   55 48 18 34 45 26 10 11   Credit rating   BBB BBB BB BBB BBB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   437 721 293 474 790 375 0.0 0.0   EBITDA   410 670 -134 161 373 -78.8 0.0 0.0   EBIT   395 655 -134 161 373 -78.8 0.0 0.0   Pre-tax profit (PTP)   396.0 654.6 -138.5 164.4 354.1 -91.4 0.0 0.0   Net earnings   307.9 508.1 -110.7 127.5 275.9 -91.4 0.0 0.0   Pre-tax profit without non-rec. items   396 655 -139 164 354 -91.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   703 811 200 327 546 396 135 135   Interest-bearing liabilities   0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,038 1,295 601 682 1,007 645 135 135   Net Debt   -553 -483 15.0 -92.0 -390 -211 -135 -135     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   437 721 293 474 790 375 0.0 0.0   Gross profit growth   25.7% 64.9% -59.4% 62.0% 66.6% -52.6% -100.0% 0.0%   Employees   1 0 1 1 1 1 0 0   Employee growth %   0.0% -100.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,038 1,295 601 682 1,007 645 135 135   Balance sheet change%   18.1% 24.8% -53.6% 13.6% 47.6% -36.0% -79.1% 0.0%   Added value   410.0 670.4 -134.4 160.6 372.7 -78.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -29 -30 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   90.5% 90.9% -45.9% 33.8% 47.2% -21.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   41.4% 56.2% -14.2% 26.2% 44.9% -9.5% 0.0% 0.0%   ROI %   69.7% 86.7% -26.0% 61.2% 86.8% -16.7% 0.0% 0.0%   ROE %   56.1% 67.2% -21.9% 48.3% 63.2% -19.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   67.7% 62.6% 33.3% 48.0% 54.2% 61.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -134.9% -72.0% -11.2% -57.3% -104.6% 268.2% 0.0% 0.0%   Gearing %   0.0% 0.0% 10.9% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.4% 0.0% 38.1% 32.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.8 2.5 1.5 1.9 2.2 2.6 0.0 0.0   Current Ratio   3.1 2.7 1.5 1.9 2.2 2.6 0.0 0.0   Cash and cash equivalent   553.3 483.0 6.8 92.0 389.9 211.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   687.6 810.6 199.9 327.4 546.1 395.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   410 0 -134 161 373 -79 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   410 0 -134 161 373 -79 0 0   EBIT / employee   395 0 -134 161 373 -79 0 0   Net earnings / employee   308 0 -111 127 276 -91 0 0